Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Human Genome Sciences    

HUMAN GENOME SCIENCES
Mes dernières consult.
Most popular
Report
 SummaryNewsCompany 
Company
More about the company
Latest news on HUMAN GENOME SCIENCES
2012 HUMAN GENOME SCIENCES : Announces required offer to repurchase in respect of its..
2012 GlaxoSmithKline Completes Acquisition of Human Genome Sciences
2012 GlaxoSmithKline Gets 79% Tenders for Human Genome Sciences Offer
2012 EXCLUSIVE : Human Genome rejected Amgen's $7 billion bid in 2010: sources
2012 HUMAN GENOME SCIENCES : Securities Lawyers at Goldfarb LLP Seeking More Money, I..
2012 HUMAN GENOME SCIENCES : Law Offices of Howard G. Smith Announces Investigation o..
2012 HUMAN GENOME SCIENCES : Law Office of Brodsky & Smith, LLC Announces Investigati..
2012 HUMAN GENOME SCIENCES : Inc. Board of Directors Under Investigation for Potentia..
2012 HUMAN GENOME SCIENCES : Ryan & Maniskas, LLP Announces Investigation of Human Ge..
2012 HUMAN GENOME SCIENCES : Robbins Umeda LLP Announces an Investigation of Human Ge..
More news
Sector news : Biotechnology & Medical Research - NEC
01/17 CELGENE : Conducts Deal Talks With Juno -- WSJ
01/16 CELGENE : in Talks to Buy Juno Therapeutics -- Update
01/16 CELGENE : in Talks to Buy Juno Therapeutics
01/12 Drugmakers see a pricing blueprint in an $850,000 gene therapy
01/12 SPARK'S PRICE FOR LUXTURNA BLINDNESS : Icer
More sector news : Biotechnology & Medical Research - NEC
Sector and Competitors
1st jan.Capitalization (M$)
HUMAN GENOME SCIENCES0
CELLTRION, INC.--.--%33 774
IQVIA HOLDINGS INC2.37%21 423
LONZA GROUP0.76%20 876
INCYTE CORPORATION-4.65%19 660
ALNYLAM PHARMACEUTICALS, INC.-1.42%12 275